GlaxoSmithKline (GSK) recalled all Alli weight loss products from U.S. and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may contain product that is not authentic Alli. Alli (60 mg orlistat capsules) is an FDA approved over-the-counter weight loss aid clinically proven to help boost weight loss efforts. GSK is conducting an investigation and is working with the knowledge of the FDA on this retailer level recall.
GSK received inquiries from consumers in seven states about bottles of Alli that contained tablets and capsules that were not Alli. A range of tablets and capsules of various shapes and colors were reported to be found inside bottles. Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic. These tampered products were purchased in retail stores.
Alli is a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat.” It is packaged in a labeled bottle that has an inner foil seal imprinted with the words: “Sealed for Your Protection.” Consumers should confirm any Alli in their possession matches this description.
See the Recall
See also Medical Law Perspectives, May 2013 Report: Drugs, Dosage, and Damage: Physician Liability for Prescribing or Administering Medication